- Scientists develop technique for better detection of breast cancer
- Cellect Biotechnology reports Q1 2019 results
- Menicon launches Menicon Bloom Myopia Control Management System
- Translational research led by Singapore scientists uncovers new treatment for fatty liver disease
- FDA permits marketing of first diagnostic test for detection of prosthetic joint infections
- Amprion's PMCA technology receives Breakthrough Device Designation from U.S. FDA
- B dot Medical to develop ultra-compact proton cancer therapy
- Taiwanese startups receive boost from French, Swiss health industry
- FDA grants marketing authorization for new Zika diagnostic test
- Fountain Healthcare Partners raises €118M for Third Fund
- Chugai’s Actemra Intravenous Infusion receives additional approval for Adult Still’s Disease
- India is doing pretty good with health IT but there are still some gaps that can be shared with Taiwan: Dr. Nina, Kao Hsiao Ling
- Phebra continues international business expansion
- Japan approves use of Elekta Unity MRI therapy system
-
China | 27 March 2019 | News
Hong Kong has the fourth-lowest health & well-being score, finds a Cigna survey
Global health service company Cigna Corporation has released the results of its 2019 Cigna 360 Well-Being Surv...Read more
India | 26 March 2019 | News
Study reveals majority cancer patients in India not getting right treatment
A study by Onco.com, the world’s first online cancer care platform, has come up with startling findings ...Read more
-
Japan | 24 May 2019 | News
Chugai’s Actemra Intravenous Infusion receives additional approval for Adult Still’s Disease
Chugai Pharmaceutical has announced that it has obtained regulatory approval for the humanized anti-human IL-6...Read more
-
Japan | 24 May 2019 | News
Scientists develop technique for better detection of breast cancer
Researchers at Okayama University report in the journal Sensors and Actuators B: Chemical that terah...Read more
-
China | 28 March 2019 | News
Medtronic launches MedTech innovation accelerator in Shanghai
Medtronic plc, the global leader in medical technology, has announced the launch of the Medtronic MedTech Inno...Read more
-
Malaysia | 27 March 2019 | News
Veeda Clinical Research successfully completes third inspection by NPRA
Veeda Clinical Research Pvt. Ltd., a leading independent CRO has announced that its clinical (Shivalik, Ahmeda...Read more
3Ps augmenting drug discovery in APAC
Beyond meeting the needs of global pharma in simply providing access to patient pools and lower operational costs, the Asia-Pacific (APAC) region is also poised to realize the potential of a thriving biotechnology sector that is driving innovation on its own. APAC is gaining the experience and infrastructure needed to support the global biotech industry by performing work and fostering innovation through public private partnership (3Ps) that is moving up the pharmaceutical value chain.
